DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Hamanishi J, Mandai M, Ikeda T. et al.
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
J Clin Oncol 2015;
33: 4015-4022
DOI: 10.1200/JCO.2015.62.3397.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.